Back to School: How biopharma can reboot drug development. Access exclusive analysis here

TetraLogic names Buchi president, CEO

Cancer company TetraLogic Pharmaceuticals (Malvern, Pa.) hired J. Kevin Buchi as president and CEO. He

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE